Table of Contents Maybe you are on Ozempic, Wegovy, Mounjaro, Zepbound, semaglutide, or tirzepatide
The Precision Peptide Genetic Test reveals predispositions in key metabolic and peptide signaling pathways, including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313
Glucose-dependent secretion
Through its innovative dual action on GIP and GLP-1 receptors, Mounjaro promotes sustainable weight loss and appetite suppression, directly addressing key factors in fatty liver development
These advancements offer hope for a more comprehensive and personalised approach to weight loss, potentially reducing the burden of obesity and its associated health problems.
Ceramosides is a registered trademark of EPI France and is used under license from Seppic, Inc